Natural Health Trends vs cbdMD
NHTC and YCBD side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NHTC and YCBD compare
Natural Health Trends is the larger company, worth 1.5 times as much as cbdMD ($6.3M against $4.2M).
cbdMD grew revenue faster over the last twelve months (10.0% versus −16.5% for Natural Health Trends).
Natural Health Trends keeps more of each dollar of sales as profit, with a net margin of −4.2% compared with −13.8% at cbdMD.
Natural Health Trends pays a dividend yielding 53.7%; cbdMD does not pay one.
Natural Health Trends scores higher on the StockData Score (12 against 10 for cbdMD), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NHTC | YCBD |
|---|---|---|
| Size and price | ||
| Market cap | $6.3M | $4.2M |
| Share price | $0.746 | $0.374 |
| Change, 1 year | −79.3% | −51.7% |
| Change, 5 years | −89.6% | −99.9% |
| Beta (5Y) | 0.73 | 0.61 |
| Employees | 120 | 42 |
| StockData Score | ||
| Total score | 12 (better) | 10 |
| Valuation score | 3 | 3 |
| Growth score | 1 | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 5 | 5 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/S | 0.2× (better) | 0.2× |
| P/B | 0.4× (better) | 0.5× |
| FCF yield | −73.7% | −57.5% (better) |
| Fair value | $2.95 | $2.22 |
| Margin of safety | 74.7% | 83.1% (better) |
| Growth | ||
| Revenue growth (TTM) | −16.5% | 10.0% (better) |
| Revenue growth, 5Y average | −8.5% (better) | −14.5% |
| Profitability | ||
| Gross margin | 74.3% (better) | 57.7% |
| Operating margin | −5.9% (better) | −13.9% |
| Net margin | −4.2% (better) | −13.8% |
| FCF margin | −13.7% | −11.5% (better) |
| Return on equity | −6.9% (better) | −40.3% |
| Return on invested capital | – | −41.2% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.13 | 2.50 (better) |
| Altman Z-score | −0.17 (better) | −17.57 |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 53.7% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 0.00% | – |
| Shareholder yield | 53.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 12.2% | 8.2% |
| Held by insiders | 13.0% | 34.6% |
| Insider net buying, 12 months | – | −$1.3M |
| Short interest, % of float | 0.61% | 6.6% |
Go deeper
- NHTC stock overview
- NHTC income statement
- NHTC valuation and score
- YCBD stock overview
- YCBD income statement
- YCBD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.